Histopathological and immunohistochemical study of hepatic stellate cells in patients with viral C chronic liver disease

Romanian Journal of Morphology and Embryology

Volumn 54, Issue 4, 2013, Pages 983-991

  Ionescu, A G ^a   Streba, Letiţia Adela Maria ^a   Vere, C C ^a   Ciurea, M E ^a   Streba, C T ^a   Ionescu, Mihaela ^b   Comǎnescu, Maria ^c   Irimia, Eugenia ^a   Rogoveanu, Otilia ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Alpha smooth muscle actin; Hepatic stellate cells; Immunohistochemical assessment; Liver fibrosis

Indexed keywords

ADULT; ARTICLE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; STELLATE CELL; VIROLOGY;

ADULT; FEMALE; HEPACIVIRUS; HEPATIC STELLATE CELLS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MIDDLE AGED;

EID: 84891621723     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ray Kim W, Global epidemiology and burden of hepatitis C, Microbes Infect, 2002, 4(12):1219-1225.
2. Gheorghe L, Iacob S, Csiki IE, Prevalence of hepatitis C in Romania: different from European rates? J Hepatol, 2008, 49(4):661-662; author reply 663.
3. Grigorescu M, Romanian Society of Gastroenterology and Hepatology, HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C, J Gastrointestin Liver Dis, 2009, 18(1):45-50.
4. Mengshol JA, Golden-Mason L, Rosen HR, Mechanisms of disease: HCV-induced liver injury, Nat Clin Pract Gastroenterol Hepatol, 2007, 4(11):622-634.
5. Spengler U, Nattermann J, Immunopathogenesis in hepatitis C virus cirrhosis, Clin Sci (Lond), 2007, 112(3):141-155.
6. Milani S, Herbst H, Schuppan D, Hahn EG, Stein H, In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells, Hepatology, 1989, 10(1):84-92.
7. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T, Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers, J Hepatol, 2002, 36(2):200-209.
8. Buniatian G, Hamprecht B, Gebhardt R, Glial fibrillary acidic protein as a marker of perisinusoidal stellate cells that can distinguish between the normal and myofibroblast-like phenotypes, Biol Cell, 1996, 87(1-2):65-73.
9. Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmoulière A, Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved, Int J Biochem Cell Biol, 2006, 38(2):135-151.
10. Schulze-Krebs A, Preimel D, Popov Y, Bartenschlager R, Lohmann V, Pinzani M, Schuppan D, Hepatitis C virusreplicating hepatocytes induce fibrogenic activation of hepatic stellate cells, Gastroenterology, 2005, 129(1):246-258.
11. The French METAVIR Cooperative Study Group, Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C, Hepatology, 1994, 20(1 Pt 1): 15-20.
12. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN et al., Histological grading and staging of chronic hepatitis, J Hepatol, 1995, 22(6):696-699.
13. Rubbia-Brandt L, Leandro G, Spahr L, Giostra E, Quadri R, Malé PJ, Negro F, Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3, Histopathology, 2001, 39(2):119-124.
14. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander- Tetri BA, Bacon BR, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, Am J Gastroenterol, 1999, 94(9):2467-2474.
15. Capuron L, Miller AH, Immune system to brain signaling: neuropsychopharmacological implications, Pharmacol Ther, 2011, 130(2):226-238.
16. Liu C, Tao Q, Sun M, Wu JZ, Yang W, Jian P, Peng J, Hu Y, Liu C, Liu P, Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats, Lab Invest, 2010, 90(12):1805-1816.
17. Friedman SL, Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver, Physiol Rev, 2008, 88(1): 125-172.
18. Bedossa P, Poynard T, Mathurin P, Lemaigre G, Chaput JC, Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon, Gut, 1993, 34(2 Suppl):S146-S147.
19. Paradis V, Mathurin P, Laurent A, Charlotte F, Vidaud M, Poynard T, Hoang C, Opolon P, Bedossa P, Histological features predictive of liver fibrosis in chronic hepatitis C infection, J Clin Pathol, 1996, 49(12):998-1004.
20. Chu CM, Shyu WC, Liaw YF, Comparative studies on expression of alpha-smooth muscle actin in hepatic stellate cells in chronic hepatitis B and C, Dig Dis Sci, 2008; 53(5): 1364-1369.
21. Baroni GS, Pastorelli A, Manzin A, Benedetti A, Marucci L, Solforosi L, Di Sario A, Brunelli E, Orlandi F, Clementi M, Macarri G, Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C, Liver, 1999, 19(3):212-219.
22. Clouston AD, Jonsson JR, Purdie DM, Macdonald GA, Pandeya N, Shorthouse C, Powell EE, Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation, J Hepatol, 2001, 34(2):314-320.
23. Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E, Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation, Dig Liver Dis, 2005, 37(5):349-356.
24. Tomanovic NR, Boricic IV, Brasanac DC, Stojsic ZM, Delic DS, Brmbolic BJ, Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study, J Gastrointestin Liver Dis, 2009, 18(2):163-167.
25. Tacke F, Weiskirchen R, Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques, Expert Rev Gastroenterol Hepatol, 2012, 6(1):67-80.
26. Sǎndulescu L, Rogoveanu I, Ciurea T, Comǎnescu MV, Streba CT, Ionescu AG, Oproaica A, Ene M, Immunohistochemical study of stellate cells in patients with chronic viral hepatitis C genotype 1, Rom J Morphol Embryol, 2011, 52(1):137-143.
27. Burt AD, Griffiths MR, Schuppan D, Voss B, MacSween RN, Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno-gold labelling, Histopathology, 1990, 16(1):53-58.
28. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ, Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors, J Clin Invest, 1998, 102(3):538-549.
29. Iredale JP, Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ, J Clin Invest, 2007, 117(3):539-548.
30. Elsharkawy AM, Oakley F, Mann DA, The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis, Apoptosis, 2005, 10(5):927-939.
31. Falcón V, Acosta-Rivero N, Shibayama M, Chinea G, Gavilondo JV, de la Rosa MC, Menéndez I, Gra B, Dueñas- Carrera S, Viña A, García W, González-Bravo M, Luna- Munoz J, Miranda-Sanchez M, Morales-Grillo J, Kouri J, Tsutsumi V, HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients, Biochem Biophys Res Commun, 2005, 329(4):1320-1328.
32. Bataller R, Paik YH, Lindquist JN, Lemasters JJ, Brenner DA, Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells, Gastroenterology, 2004, 126(2):529-540.
33. Khan MA, Poulos JE, Brunt EM, Li L, Solomon H, Britton RS, Bacon BR, Di Bisceglie AM, Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy, Hepatogastroenterology, 2001, 48(37):212-215.
34. Friedman SL, Liver fibrosis - from bench to bedside, J Hepatol, 2003, 38(Suppl 1):S38-S53.
35. Koike K, Miyoshi H, Oxidative stress and hepatitis C viral infection, Hepatol Res, 2006, 34(2):65-73.
36. Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, Adinolfi LE, Asselah T, Jonsson JR, Smedile A, Terrault N, Pazienza V, Giordani MT, Giostra E, Sonzogni A, Ruggiero G, Marcellin P, Powell EE, George J, Negro F; HCV Meta-Analysis (on) Individual Patients' Data Study Group, Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data, Gastroenterology, 2006, 130(6):1636-1642.
37. Vere CC, Neagoe D, Streba CT, Prejbeanu I, Ianoşi G, Comǎnescu V, Pirici D, Steatosis and serum lipid patterns in patients with chronic viral hepatitis: differences related to viral etiology, Rom J Morphol Embryol, 2010, 51(3):509-514.
38. Streba CT, Pirici D, Vere CC, Mogoantǎ L, Comǎnescu V, Rogoveanu I, Fractal analysis differentiation of nuclear and vascular patterns in hepatocellular carcinomas and hepatic metastasis, Rom J Morphol Embryol, 2011, 52(3):845-854.